WEBINAR

We invite you to explore and enjoy the webinars where the
5 national and international finalist clinical cases were presented

INTERNATIONAL WEBINAR (September 17, 2024) (English)

INTERNATIONAL WINNER

  • REGRESSION OF HIGH-GRADE CIN AND VaIN AFTER TREATMENT WITH PAPILOCARE® IN A PATIENT UNDER 25 YEARS OF AGE. Dr. Pham Ho Thuy Ai (Tu Du Hospital, Vietnam)

INTERNATIONAL FINALIST

  • COLPOSCOPIC IMPROVEMENT OF LOW-GRADE CERVICAL HPV LESIONS FOLLOWING TREATMENT WITH PAPILOCARE® FOR 6 MONTHS. Dr. Doris María Castillo Gutiérrez (Hospital Español de Veracruz, México)
  • CONSERVATIVE APPROACH TREATMENT WITH PAPILOCARE® IN NULIPARA PATIENT WITH POSITIVE HSIL SURGICAL MARGINE AFTER SECOND LOOP EXCISION PROCEDURE. Dr. Aljosa Mandic (Oncology Institute of Vojvodina, Serbia)
  • TREATMENT OF A 25-YEAR-OLD WOMAN PRESENTING WITH A LOW-GRADE SQUAMOUS INTRAEPITHELIAL LESION (LSIL) AND HPV 16. Dr. Van Thang Nguyen (The National Hospital for Gyneco-Obstetrics, Vietnam)
  • TREATMENT WITH PAPILOCARE® IN PATIENT WITH CERVICAL CONDYLOMA, HPV CERVICITIS AND ANOGENITAL WARTS. Dr. Pavlina Korunoska (University Clinic for Gynecology and Obstetrics UGAK, North Macedonia)

NATIONAL WEBINAR (September 18, 2024) (Spanish)

NATIONAL WINNER

  • MEDICAL TREATMENT OF HIGH-GRADE CERVICAL DYSPLASIA WITH PAPILOCARE®. Dr. Sabela Iglesias Faustino (Hospital Público Álvaro Cunqueiro, Vigo)

NATIONAL FINALISTS

  • ADJUVANT TREATMENT WITH PAPILOCARE® IN HIGH-GRADE CERVICAL LESIONS.  Dr. Carla Gómez Ortiz, Dr. María Pineda Mateo (Hospital Universitario Virgen Macarena, Sevilla)
  • VULVAR, VAGINAL AND CERVICAL CONDYLOMATOSIS IN PREGNANT PATIENTS: NON-PHARMACOLOGICAL TREATMENT WITH A GOOD, EARLY RESPONSE. Dr. María Ruiz Olivares (Clínica Sanabria, Granada)
  • ENDOCERVICAL LSIL. NOT JUST A MATTER OF WAITING. Dr. Inmaculada Nicolás Perea1, Dr. Josep Cararach Ramoneda2, Dr. Adrian Puche Gallego1 (1Hospital HM Sant Jordi, Barcelona. 2Institut Cararach, Barcelona)
  • LSIL-CIN 1 TREATED WITH CORIOLUS VERSICOLOR-BASED VAGINAL GEL (PAPILOCARE® VAGINAL GEL) AND IMMUNITY BOOSTER (PAPILOCARE® INMUNOCAPS) IN AN IMMUNOCOMPROMISED PATIENT. VIRAL CLEARANCE AND RESOLUTION OF THE CERVICAL LESION. Dr. Rafael José Navarro Ávila (Hospital MD Anderson Cancer Center, Madrid)